Gene · 554213
Papers1,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bisphenol A induces cellular senescence in SW1353 chondrocytes via miRNA-449a-mediated downregulation of SIRT1. | Ecotoxicol Environ Saf | 2025 | 40848421 | PubTator, text mining | PubMed |
| Determination of miRNA in tear extracellular vesicles significantly associated with treatment-requiring retinopathy of prematurity: a pilot study. | Sci Rep | 2025 | 40835875 | PubTator, text mining | PubMed |
| From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy. | Front Nutr | 2025 | 40808836 | PubTator, text mining | PubMed |
| hsa-miR-520d-3p and hsa-miR-449a are Candidate MicroRNA Regulators in Multiple Sclerosis. | Iran J Med Sci | 2025 | 40786190 | PubTator, text mining | PubMed |
| Beyond linear: How circRNAs twist and turn Notch signaling. | J Cell Commun Signal | 2025 | 40761890 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Advances in mesenchymal stem cells and their derivatives for promoting peripheral nerve regeneration. | Burns Trauma | 2025 | 40740686 | PubTator, text mining | PubMed |
| miRNAs as Biomarkers and Therapeutic Targets in Celiac Disease: Current Advances and Future Directions. | J Biochem Mol Toxicol | 2025 | 40551536 | PubTator, text mining | PubMed |
| Tanshinone IIA inhibits neuronal ferroptosis and relieves cerebral ischemia‒reperfusion injury by regulating miR-449a/ACSL4. | Metab Brain Dis | 2025 | 40542896 | PubTator, text mining | PubMed |
| Evaluation of miR-27a-5p and miR-449a as potential serum biomarkers for breast cancer: a combined bioinformatics and experimental study. | Mol Biol Rep | 2025 | 40512278 | PubTator, text mining | PubMed |
| Alterations in the Expression of a Set of miRNAs in Endometrial Cancer and Their Correlation with Clinical Variables and the p53 Signaling Pathway. | Int J Mol Sci | 2025 | 40508024 | PubTator, text mining | PubMed |
| Comprehensive analysis of the LINC01122/TPD52 axis as a predictive biomarker in prostate adenocarcinoma. | Sci Rep | 2025 | 40341647 | PubTator, text mining | PubMed |
| Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer. | Mol Med | 2025 | 40133809 | PubTator, text mining | PubMed |
| Molecular Crosstalk by miR-449a and miR-34b in endometrial and ovarian cancer cells in vitro. | Gene | 2025 | 39965746 | PubTator, text mining | PubMed |
| Robust antiviral innate immune response and miRNA regulatory network were identified in ZIKV-infected cells: implications in the pathogenesis of ZIKV infection. | Virus Genes | 2025 | 39955676 | PubTator, text mining | PubMed |
| miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. | Cell Rep | 2025 | 39799567 | PubTator, text mining | PubMed |
| LncRNA EGFR‑AS1 promotes lung cancer cell proliferation, invasion and metastasis via regulation of miR‑449a/HDAC1. | Exp Ther Med | 2025 | 39720671 | PubTator, text mining | PubMed |
| Profiling mRNA and miRNA expression variations associated with cyclin-dependent kinase pathway in the low-grade luminal early breast cancer. | J Appl Genet | 2025 | 39373948 | PubTator, text mining | PubMed |
| Platelet-Derived Microvesicles Mediate Cardiomyocyte Ferroptosis by Transferring ACSL1 During Acute Myocardial Infarction. | Mol Biotechnol | 2025 | 38466505 | PubTator, text mining | PubMed |
| MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis. | Int J Mol Sci | 2024 | 39684593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554213/papers?page=2